What is Urgent Team?
Urgent Team operates a substantial network of 51 urgent and family care centers under four distinct brands: Urgent Team, Physicians Care, Sherwood Urgent Care, and Baptist Health Urgent Care. These centers are strategically located across Alabama, Arkansas, Mississippi, and Tennessee, offering a wide spectrum of healthcare services. The company focuses on providing quality and affordable family healthcare, including treatment for common illnesses and injuries, as well as occupational health and wellness services. Its extensive footprint positions it as a major independent player in the regional healthcare landscape, catering to immediate healthcare needs with convenient, walk-in access.
How much funding has Urgent Team raised?
Urgent Team has raised a total of $68.1M across 4 funding rounds:
Private Equity
$25.8M
Unspecified
$35M
Private Equity
$5.3M
Debt
$2M
Private Equity (2012): $25.8M with participation from SV Life Sciences Advisers and River Cities Capital
Unspecified (2012): $35M led by RC Capital, Petra Capital Partners, and SV Life Sciences
Private Equity (2014): $5.3M supported by River Cities Capital Funds, SV Life Sciences Advisers, LLP, and Petra Capital Partners, LLC
Debt (2020): $2M featuring PPP
Key Investors in Urgent Team
RC Capital
RC Capital is a growth equity firm focused on building high-potential healthcare companies by leveraging the interplay of medical devices, healthcare services, and healthcare IT. The firm is dedicated to investing in companies that enhance patient outcomes and improve the delivery of care.
Petra Capital Partners
Petra Capital Partners is a private equity firm that operates with a specialized focus on providing growth-oriented capital solutions to lower middle market companies. Headquartered in Nashville, Tennessee, the firm has established itself as a pioneer in the growth capital investment model, emphasizing flexibility, partnership, and long-term value creation.
SV Life Sciences
SV Health Investors is a specialist investment firm backing innovative health care and life science companies, partnering with founders and management to provide capital, sector expertise and active support from early growth through scale and value creation.
What's next for Urgent Team?
The company's history of securing substantial capital, including significant private equity and growth equity investments from firms like RC Capital and SV Life Sciences, indicates a strategy focused on expansion and operational enhancement. The recent debt financing in 2020 suggests a phase of optimizing its capital structure or funding specific growth initiatives. As Urgent Team continues to operate and potentially expand its network, future strategic investments or financing rounds may be directed towards further market penetration, technological integration within its service delivery, or enhancing patient care capabilities across its multiple brands.
See full Urgent Team company page
